U.S. FDA Approves Anti-Epileptic Agent Banzel® (Rufinamide) Oral Suspension, 40mg/Ml
Links shared publicly online about this topic.
- 461total visits
U.S. FDA Approves Anti-Epileptic Agent Banzel® (Rufinamide) Oral Suspension, 40mg/Ml
View full resource at medicalnewstoday.com
Tags: Diet and Nutrition, Drug, FDA, Eisai
Most Recently Shared on March 5, 2011 at 8:57 pm By:
U.S. FDA Approves Anti-Epileptic Agent Banzel® (Rufinamide) Oral Suspension, 40mg/Ml: Eisai Co., Ltd. (Headquar... http://bit.ly/hWymAh
U.S. FDA Approves Anti-Epileptic Agent Banzel® (Rufinamide) Oral Suspension, 40mg/Ml
medicalnewstoday.com — “Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, Eisai) and its U.S. subsidiary Eisai Inc. announced that the United States Food and Drug Administration (FDA) approved the com” View full resource at medicalnewstoday.com
Most Recently Shared on March 5, 2011 at 9:05 am By:
U.S. FDA Approves Anti-Epileptic Agent Banzel® (Rufinamide) Oral Suspension, 40mg/Ml http://mnt.to/3RW7 #epilepsy
Advertisement

